BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12528796)

  • 1. Chemosensitivity testing of human tumors using Si-sensor chips.
    Mestres-Ventura P
    Recent Results Cancer Res; 2003; 161():26-38. PubMed ID: 12528796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of silicon sensor technologies to tumor tissue in vitro: detection of metabolic correlates of chemosensitivity.
    Mestres-Ventura P; Morguet A; Schofer A; Laue M; Schmidt W
    Methods Mol Med; 2005; 111():109-25. PubMed ID: 15911976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric sensor chips for chemosensitivity testing of sensitive and resistant tumor cells.
    Otto AM; Brischwein M; Grothe H; Motrescu E; Wolf B
    Recent Results Cancer Res; 2003; 161():39-47. PubMed ID: 12528797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of small-cell lung cancer cell-based sensor and its applications in chemotherapy effects rapid evaluation for anticancer drugs.
    Guohua H; Hongyang L; Zhiming J; Danhua Z; Haifang W
    Biosens Bioelectron; 2017 Nov; 97():184-195. PubMed ID: 28599178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphysiological testing for chemosensitivity of living tumor cells with multiparametric microsensor chips.
    Otto AM; Brischwein M; Niendorf A; Henning T; Motrescu E; Wolf B
    Cancer Detect Prev; 2003; 27(4):291-6. PubMed ID: 12893077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay.
    Henning T; Brischwein M; Baumann W; Ehret R; Freund I; Kammerer R; Lehmann M; Schwinde A; Wolf B
    Anticancer Drugs; 2001 Jan; 12(1):21-32. PubMed ID: 11272283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of drug action on tumor cell metabolism using electronic sensor chips.
    Otto AM; Brischwein M; Motrescu E; Wolf B
    Arch Pharm (Weinheim); 2004 Dec; 337(12):682-6. PubMed ID: 15597401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro testing of chemosensitivity in physiological hypoxia.
    Grigoryan R; Keshelava N; Anderson C; Reynolds CP
    Methods Mol Med; 2005; 110():87-100. PubMed ID: 15901930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress of individualized chemotherapy guided by chemosensitivity test].
    Mi YJ; Zhang CZ; Fu LW
    Yao Xue Xue Bao; 2009 Nov; 44(11):1187-92. PubMed ID: 21355317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 11. Methods and goals for the use of in vitro and in vivo chemosensitivity testing.
    Blumenthal RD; Goldenberg DM
    Mol Biotechnol; 2007 Feb; 35(2):185-97. PubMed ID: 17435285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer.
    Kornmann M; Beger HG; Link KH
    Recent Results Cancer Res; 2003; 161():180-95. PubMed ID: 12528808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced dynamic monitoring of cellular status using label-free and non-invasive cell-based sensing technology for the prediction of anticancer drug efficacy.
    Ona T; Shibata J
    Anal Bioanal Chem; 2010 Nov; 398(6):2505-33. PubMed ID: 20890782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assays of chemotherapeutic sensitivity.
    Carney DN; Winkler CF
    Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring respiration of cultured cell with oxygen electrode as a metabolic indicator for drug screening.
    Amano Y; Okumura C; Yoshida M; Katayama H; Unten S; Arai J; Tagawa T; Hoshina S; Hashimoto H; Ishikawa H
    Hum Cell; 1999 Mar; 12(1):3-10. PubMed ID: 10457900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
    Nogaki M; Ichihashi H
    Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.
    Kurbacher CM; Grecu OM; Stier U; Gilster TJ; Janát MM; Untch M; Konecny G; Bruckner HW; Cree IA
    Recent Results Cancer Res; 2003; 161():221-30. PubMed ID: 12528810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitivity testing in malignant melanoma.
    Ugurel S; Tilgen W; Reinhold U
    Recent Results Cancer Res; 2003; 161():81-92. PubMed ID: 12528801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualizing chemotherapy for solid tumors--is there any alternative?
    Cree IA; Kurbacher CM
    Anticancer Drugs; 1997 Jul; 8(6):541-8. PubMed ID: 9300568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.